相关实验视频
Updated: Mar 10, 2026

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
17.1K
肥胖的竞争性心脏代谢途径和与代谢功能障碍相关的脂肪性肝病
Masashi Hirooka1, Teruki Miyake2, Ryo Yano2
1Total Medical Support Center, Ehime University Hospital, Toon, Japan.
Gastro hep advances
|March 9, 2026
概括
与肥胖相关的代谢功能障碍相关的脂肪性肝病 (MASLD) 的发展似乎与高血压途径相竞争. 高BMI增加了MASLD的风险,但当考虑MASLD作为竞争事件时,与高血压相反地相关.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 心血管健康的心血管健康
- 肝脏疾病研究 肝脏疾病研究
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 的进展受其他代谢障碍的影响.
- 关于疾病途径竞争的定量证据仍然有限.
- 调查与肥胖相关的MASLD,高血压和2型糖尿病途径之间的竞争至关重要.
研究的目的:
- 确定与肥胖相关的MASLD发展是否与高血压和2型糖尿病途径相竞争.
- 量化高BMI,MASLD,高血压和2型糖尿病之间的关系.
- 为了探索肥胖症中明显的代谢途径进展.
主要方法:
- 一项为期13年的前性队列研究 (2007-2020年) 参与了16770名参与者.
- 竞争性风险生存分析以模拟MASLD,高血压或2型糖尿病的首次发生.
- 根据年龄,性别和心脏代谢参数调整的分发危险比率 (HRs).
主要成果:
- 高BMI (≥25 kg/m2) 强烈增加了MASLD风险 (aHR:4.54).
- 在传统分析中,高BMI增加了高血压风险 (HR: 1.12).
- 竞争性风险分析显示,高BMI和MASLD对高血压的发展之间存在反向关联 (shHR:0.87),这表明路径竞争.
结论:
- 发展为MASLD的高BMI个体的随后高血压发生率较低.
- 显而易见的反向关联表明竞争的代谢途径 (肝脏与血管).
- 这些发现支持肥胖相关代谢功能障碍的表型特异性风险分层.
相关概念视频
Overview of Lipid Metabolism
6.3K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
259
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259
Liver Physiology
4.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
246
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
246
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
305
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
305
Overview of Fatty Acid Metabolism
37.5K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.5K

